Literature DB >> 16508890

The neurochemical circuitry of schizophrenia.

A Carlsson1.   

Abstract

The aim of this paper is to describe the connectivity of some basic neuronal circuits assumed to be causally related to the generation of symptoms in schizophrenia. The role of various transmitter substances like dopamine, glutamate, serotonin and GABA can be explained by the circuitry of the respective pathways in the brain. Activating and inhibiting loops that are coupled can shift into an imbalance that might result in the generation of positive and negative symptoms. Finally, the paper draws attention to the hypothesis that extrasynaptic receptors might play an important role in schizophrenia. The paper shows that thinking in loops might be an efficient strategy for obtaining a functional understanding of the neuronal circuitry involved in the complex symptomatology of schizophrenia. Those models help us to understand the action of antipsychotic medications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508890     DOI: 10.1055/s-2006-931483

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  46 in total

1.  Executive control in chronic schizophrenia: A perspective from manual stimulus-response compatibility task performance.

Authors:  Simone D Behrwind; Manuel Dafotakis; Sarah Halfter; Kerstin Hobusch; Mark Berthold-Losleben; Edna C Cieslik; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

2.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

Review 3.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

Review 4.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

5.  Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.

Authors:  P A Ardayfio; A Leung; J Park; D-Y Hwang; T Moran-Gates; Y K Choi; W A Carlezon; F I Tarazi; K S Kim
Journal:  Neuroscience       Date:  2009-12-22       Impact factor: 3.590

6.  Elevated gamma-aminobutyric acid levels in chronic schizophrenia.

Authors:  Dost Ongür; Andrew P Prescot; Julie McCarthy; Bruce M Cohen; Perry F Renshaw
Journal:  Biol Psychiatry       Date:  2010-07-02       Impact factor: 13.382

7.  Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain.

Authors:  Nina Segnitz; Thomas Ferbert; Andrea Schmitt; Peter Gass; Peter J Gebicke-Haerter; Mathias Zink
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

Review 8.  [Sexual hallucinations and dreams under anesthesia and sedation : medicolegal aspects].

Authors:  C Schneemilch; K Schiltz; E Meinshausen; T Hachenberg
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 9.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.

Authors:  P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  Trends Pharmacol Sci       Date:  2008-12-06       Impact factor: 14.819

10.  Identification of a serotonin/glutamate receptor complex implicated in psychosis.

Authors:  Javier González-Maeso; Rosalind L Ang; Tony Yuen; Pokman Chan; Noelia V Weisstaub; Juan F López-Giménez; Mingming Zhou; Yuuya Okawa; Luis F Callado; Graeme Milligan; Jay A Gingrich; Marta Filizola; J Javier Meana; Stuart C Sealfon
Journal:  Nature       Date:  2008-02-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.